21comL

The Week Ahead: Mag 7 report earnings, Fed to cut rates again and Trump to meet China’s Xi

Neil Wilson
Investor Content Strategist

Summary:  Your guide to the trading week covering 27 -31 October. Note: This is marketing material. This article is not investment advice, capital is at risk.

Your guide to the trading week ahead covering 27 - 31 October

It’s about as busy a week as you can get for financial markets.

  • US earnings season hits warp speed as 5 of the Mag7 stocks report

  • President Donald Trump will meet Chinese President Xi Jinping

  • The Federal Reserve is widely expected to cut rates again

  • The Bank of Japan, Bank of Canada and ECB are also in action

  • US government shutdown delays data releases

  • APEC meetings shine spotlight on Asia

Monday, 27 October

Not the fastest start to the week with just a smattering of mid-tier economic data and no major earnings.

Donald Trump is on a multi-country visit to Asia that’s expected to include meetings with Sanae Takaichi, Japan’s first female prime minister. It comes at the start of a week of APEC meetings in South Korea that will put the focus on Asian economies and trade.

Tuesday, 28 October

Earnings season in the US continues with PayPal, UnitedHealth Group, Booking Holdings, Mondelez and Visa among the large cap stocks to report. HSBC is the major UK listed company to report, while BNP Paribas reports in Paris.

Investors always pay close attention to what Nvidia CEO Jensen Huang has to say - he delivers a keynote address at the company’s GPU Technology Conference in Washington.

Wednesday, 29 October

The Federal Reserve is widely anticipated to cut rates for the second month in a row, with investors looking out for signs of whether a third will come before the end of the year. The Bank of Canada is also expected to cut but sticky inflation has cast a little extra doubt on the outcome of the meeting.

Earnings come from Boeing, Caterpillar, Etsy, Starbucks and three Magnificent 7 stocks – Meta Platforms, Microsoft and Alphabet. On the FTSE, GSK reports.

The Netherlands holds a snap election triggered by the collapse of Prime Minister Dick Schoof’s government in June after Geert Wilders pulled his Freedom party (PVV) out of the 11-month-old ruling coalition.

Thursday, 30 October

US president Donald Trump will meet his Chinese counterpart today on the sidelines of the Asia-Pacific Economic Cooperation, or APEC, Summit. Trump last met Chinese President Xi Jinping in 2019 and the mood of the talks will be important for risk sentiment as the high stakes meeting comes at a key moment relating to trade and tariffs. The trade truce between the two countries expires on 10 November, while Trump has also set a 1 November date for imposing additional 100% tariffs.

The European Central Bank decision is unlikely to have much impact – all eyes are on the December meeting. The Bank of Japan could offer more excitement as it holds its first policy meeting since the election of pro-stimulus fiscal dove Takaichi. It also comes after inflation rose to 2.9% year-on-year in September from the previous month’s 2.7%. The prevailing thinking is that we see a split vote at this meeting and the next hike in December.

US earnings come from Eli Lilly, Mastercard, Estee Lauder, Apple and Amazon. Crypto stocks Coinbase, Riot and Strategy are all due to provide earnings updates as well. In London, Shell and Standard Chartered are due to report.

Friday, 31 October

Earnings week comes to a close on Wall Street with AbbVie, Aon, Chevron and Exxon Mobil due to report.

Nvidia CEO Jensen Huang is back again as he and Citigroup CEO Jane Fraser are among the speakers on the last day of the APEC CEO Summit in South Korea.

On the data front, Chinese PMI data will be one to watch for risk sentiment at the start of the European session – albeit any fallout or progress on trade from those Trump-Xi talks will be the most important thing. Eurozone CPI numbers are out, and US PCE inflation is slated but unlikely to appear due to the shutdown.

 

 

 

Check the calendar for all upcoming events.

Check outlast month's most popular shares.

Quarterly Outlook

01 /

  • Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Quarterly Outlook

    Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    Quarterly Outlook

    Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    John J. Hardy

    Global Head of Macro Strategy

    The Fed launched a new easing cycle in late Q3. Will this cycle now play out like 2000 or 2007?
  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992